AI Article Synopsis
- - The study aimed to compare the safety and effectiveness of transluminal foam sclerotherapy combined with endovenous laser ablation (EVLA) against EVLA alone for treating small saphenous vein incompetence, focusing on changes in the venous clinical severity score (VCSS) over one year.
- - Researchers conducted the study by using a sheath for foam sclerotherapy during the EVLA procedure, assessing various outcomes such as VCSS changes, reflux recurrence, and complications at multiple time points after treatment.
- - Results indicated that while the change in VCSS wasn't significantly impactful, the combination treatment (TLFS + EVLA) led to lower rates of residual or recurrent reflux compared to EVLA alone, suggesting TLFS
Article Abstract
Objectives: To compare foam sclerotherapy through the access sheath (transluminal foam sclerotherapy [TLFS]) combined with endovenous laser ablation (EVLA) with EVLA alone in terms of safety and one-year venous clinical severity score (VCSS) changes in patients with small saphenous vein incompetence.
Methods: During EVLA, the sheath tip was placed around the targeted tributary vein, and the sclerosant was injected via the side port. Outcomes assessed at 1 day, 1 week, 1 month, and 1 year included VCSS changes, residual or recurrent reflux, the need for secondary interventions, and other related complications.
Results: The change in VCSS did not reach the minimum clinically important difference. Otherwise, TLFS reduced residual or recurrent reflux of the tributary using the TLFS (3/74 legs) compared with the EVLA alone (12/77 legs) ( = .027).
Conclusions: TLFS is a safe and feasible procedure that reduces residual or recurrent reflux of the tributary vein compared with truncal EVLA alone.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/02683555241276709 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!